Biostar Pharmaceuticals, Inc. Financing Receivable, after Allowance for Credit Loss, Current
Biostar Pharmaceuticals, Inc. had Financing Receivable, after Allowance for Credit Loss, Current of $0 as of 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2015-04-15
- 2012-12-31: Financing Receivable, after Allowance for Credit Loss, Current 60.00M CNY.
- 2012-11-20: Financing Receivable, after Allowance for Credit Loss, Current 60.00M CNY.
CNY
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | 60.00M CNY 10-Q · filed 2014-05-15 |
| 2012-11-20 | 60.00M CNY 10-Q · filed 2014-11-14 |
USD
| Period end | Financing Receivable, after Allowance for Credit Loss, Current | Financing Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-04-15 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $9.75M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $10.05M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.64M 10-K · filed 2015-04-15 | $9.82M 10-K · filed 2014-03-31 |
| 2013-09-30 | $10.85M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $10.48M 10-Q · filed 2013-08-19 | |
| 2013-03-31 | $10.01M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $9.50M 10-Q · filed 2014-05-15 | $9.51M 10-K · filed 2013-04-15 |
| 2012-11-20 | $9.50M 10-Q · filed 2014-11-14 | |
| 2011-12-31 | $0.00 10-K · filed 2013-04-15 |